Amgen Highlights MariTide, IMDELLTRA Pipeline Progress and Growth Priorities
MarketBeat
Amgen (NASDAQ:AMGN) outlined its growth priorities, late-stage pipeline progress and capital-allocation framework during a Morgan Stanley conference, as newly appointed Chief Financial Officer Thomas Dittrich emphasized execution, financial discipline and cash-on-cash returns.
Dittrich, who previou
NASDAQ:AMGN